Household costs and health-related quality of life of childhood MDR-TB in Western Cape, South Africa
Abstract
Background
Multidrug-resistant (MDR) tuberculosis (TB) in children remains a major public health challenge. Although treatment is provided free of direct charge in many countries, it can impose substantial indirect and non-medical costs on affected households. Evidence on the economic burden of childhood MDR-TB on families, remains limited.
Methods
A cross-sectional household survey was conducted in the Western Cape, South Africa, among 45 households with a child <15 years who initiated MDR-TB treatment between 2018 and 2021. Socioeconomic status, costs of accessing care, and health-related quality of life (HRQoL) were assessed and linked to health service utilisation data to estimate household-level costs.
Results
The median total cost per household was ZAR 7,443 (US$504) per episode of care (IQR: ZAR 4,119– 13,207), with indirect costs accounting for the largest share of household costs. Twenty-three (51.1%) of the households incurred catastrophic health expenditure, defined as >20% of annual household income. Costs increased with hospital-based care, longer treatment duration, and more frequent caregiver visits. The HRQoL of children was generally high, though not uniformly distributed.
Conclusions
Childhood MDR-TB places a substantial financial burden on already vulnerable households. Economic evaluations and care models should incorporate household costs and consider strategies to reduce the indirect burden of treatment on families.
Related articles
Related articles are currently not available for this article.